- Business Wire2026. 07. 15. 05:00
Alkermes to Report Second Quarter Financial Results on July 28, 2026 - Business Wire
Alkermes to Report Second Quarter Financial Results on July 28, 2026 Business Wire
- Business Wire2026. 07. 15. 05:00
Alkermes to Report Second Quarter Financial Results on July 28, 2026
- Moomoo2026. 07. 14. 18:48
Needham Maintains Alkermes(ALKS.US) With Buy Rating, Raises Target Price to $62 - Moomoo
Needham Maintains Alkermes(ALKS.US) With Buy Rating, Raises Target Price to $62 Moomoo
- BioSpace2026. 07. 14. 01:31
Alkermes’ Alixorexton Demonstrated Sustained Improvement in Wakefulness in Adults With Narcolepsy Type 1 and Type 2 in Long-Term Extension Study Interim Analysis - BioSpace
Alkermes’ Alixorexton Demonstrated Sustained Improvement in Wakefulness in Adults With Narcolepsy Type 1 and Type 2 in Long-Term Extension Study Interim Analysis BioSpace
- Yahoo2026. 07. 14. 01:12
Alkermes releases nine-month data as OX2R race heats up - Yahoo
Alkermes releases nine-month data as OX2R race heats up Yahoo
- Clinical Trials Arena2026. 07. 14. 01:12
Alkermes releases nine-month data as OX2R race heats up
